Article de Périodique
Legal piperazine-containing party pills-a new trend in substance misuse (2007)
(Pilules légales du milieu festif contenant de la piperazine : nouvelle tendance dans le mésusage de produits)
Auteur(s) :
J. SHERIDAN ;
R. BUTLER ;
C. WILKINS ;
B. RUSSELL
Article en page(s) :
335-343
Refs biblio. :
68
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus mots-clés
MDMA-ECSTASY
;
MILIEU FESTIF
;
EFFET SECONDAIRE
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
REPRESSION
Note générale :
Drug and Alcohol Review, 2007, 26, (3), 335-343
Résumé :
ENGLISH :
In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as 'safe' alternatives' to 'illicit' drugs often used in the dance scene such as MDMA and amphetamines. The authors describe the availability and use of these substances in New Zealand, summarize what is known about their effects, and speculate on harm reduction interventions and mechanisms of control and their possible sequelae. The paper provides a timely account of an emerging drug issue of relevance to harm reduction internationally. (Author' s abstract)
ENGLISH :
In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as 'safe' alternatives' to 'illicit' drugs often used in the dance scene such as MDMA and amphetamines. The authors describe the availability and use of these substances in New Zealand, summarize what is known about their effects, and speculate on harm reduction interventions and mechanisms of control and their possible sequelae. The paper provides a timely account of an emerging drug issue of relevance to harm reduction internationally. (Author' s abstract)
Affiliation :
The School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, New Zealand. j.sheridan@auckland.ac.nz
Nouvelle Zélande. New Zealand.
Nouvelle Zélande. New Zealand.